首页> 美国卫生研究院文献>PLoS Neglected Tropical Diseases >The Case for Live Attenuated Vaccines against the Neglected Zoonotic Diseases Brucellosis and Bovine Tuberculosis
【2h】

The Case for Live Attenuated Vaccines against the Neglected Zoonotic Diseases Brucellosis and Bovine Tuberculosis

机译:针对被忽视的人畜共患病布鲁氏菌病和牛结核病的减毒活疫苗的病例

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Vaccination of humans and animals with live attenuated organisms has proven to be an effective means of combatting some important infectious diseases. In fact, the 20th century witnessed tremendous improvements in human and animal health worldwide as a consequence of large-scale vaccination programs with live attenuated vaccines (LAVs). Here, we use the neglected zoonotic diseases brucellosis and bovine tuberculosis (BTb) caused by Brucella spp. and Mycobacterium bovis (M. bovis), respectively, as comparative models to outline the merits of LAV platforms with emphasis on molecular strategies that have been pursued to generate LAVs with enhanced vaccine safety and efficacy profiles. Finally, we discuss the prospects of LAV platforms in the fight against brucellosis and BTb and outline new avenues for future research towards developing effective vaccines using LAV platforms.
机译:用减毒活生物体对人和动物进行疫苗接种已被证明是抗击某些重要传染病的有效手段。实际上,由于采用减毒活疫苗(LAV)进行的大规模疫苗接种计划,全球20世纪的人类和动物健康状况得到了极大改善。在这里,我们使用由布鲁氏菌属引起的被忽视的人畜共患疾病布鲁氏菌病和牛结核病(BTb)。牛分枝杆菌和牛分枝杆菌(牛分枝杆菌)分别作为比较模型,概述了LAV平台的优点,并重点研究了分子策略,这些策略已被采用来产生具有增强的疫苗安全性和功效特征的LAV。最后,我们讨论了LAV平台在对抗布鲁氏菌病和BTb方面的前景,并概述了未来研究的新途径,以期开发使用LAV平台的有效疫苗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号